Clinical Trials Browser

Active not recruiting × Neoplasms × ibrutinib × Clear all

NCT04263480 2025-04-04

CZAR-1

Phase 2 Active not recruiting

Waldenstrom Macroglobulinemia, Neoplasms

NCT03422393 2024-07-05

Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib

Phase 1 Active not recruiting

LymphoidOther hematologic neoplasm

Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Disease Progression